JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demura, Y.
Right arrow Articles by Yonekura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demura, Y.
Right arrow Articles by Yonekura, Y.
Journal of Nuclear Medicine Vol. 44 No. 4 540-548
© 2003 by Society of Nuclear Medicine


Clinical Investigations

18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax

Yoshiki Demura, MD1, Tatsuro Tsuchida, MD2, Takeshi Ishizaki, MD3, Shiro Mizuno, MD1, Yoshitaka Totani, MD1, Shingo Ameshima, MD1, Isamu Miyamori, MD1, Masato Sasaki, MD4 and Yoshiharu Yonekura, MD5

1 Third Department of Internal Medicine, Fukui Medical University, Fukui, Japan
2 Department of Radiology, Fukui Medical University, Fukui, Japan
3 Department of Fundamental Nursing, Fukui Medical University, Fukui, Japan
4 Second Department of Surgery, Fukui Medical University, Fukui, Japan
5 Biomedical Imaging Research Center, Fukui Medical University, Fukui, Japan

Recent reports have indicated the value and limitations of 18F-FDG PET and 201Tl SPECT for determination of malignancy. We prospectively assessed and compared the usefulness of these scintigraphic examinations as well as 18F-FDG PET delayed imaging for the evaluation of thoracic abnormalities. Methods: Eighty patients with thoracic nodular lesions seen on chest CT images were examined using early and delayed 18F-FDG PET and 201Tl-SPECT imaging within 1 wk of each study. The results of 18F-FDG PET and 201Tl SPECT were evaluated and compared with the histopathologic diagnosis. Results: Fifty of the lesions were histologically confirmed to be malignant, whereas 30 were benign. On 18F-FDG PET, all malignant lesions showed higher standardized uptake value (SUV) levels at 3 than at 1 h, and benign lesions revealed the opposite results. Correlations were seen between 18F-FDG PET imaging and the degree of cell differentiation in malignant tumors. No significant difference in accuracy was found between 18F-FDG PET single-time-point imaging and 201Tl SPECT for the differentiation of malignant and benign thoracic lesions. However, the retention index (RI) of 18F-FDG PET (RI-SUV) significantly improved the accuracy of thoracic lesion diagnosis. Furthermore, 18F-FDG PET delayed imaging measuring RI-SUV metastasis was useful for diagnosing nodal involvement and it improved the specificity of mediastinal staging. Conclusion: No significant difference was found between 18F-FDG PET single-time-point imaging and 201Tl SPECT for the differentiation of malignant and benign thoracic lesions. The RI calculated by 18F-FDG PET delayed imaging provided more accurate diagnoses of lung cancer.

Key Words: 18F-FDG PET • 201Tl SPECT • retention index • lung cancer • nodal staging




This article has been cited by other articles:


Home page
ChestHome page
G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck
Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 178S - 201S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Mavi, M. Urhan, J. Q. Yu, H. Zhuang, M. Houseni, T. F. Cermik, D. Thiruvenkatasamy, B. Czerniecki, M. Schnall, and A. Alavi
Dual Time Point 18F-FDG PET Imaging Detects Breast Cancer with High Sensitivity and Correlates Well with Histologic Subtypes
J. Nucl. Med., September 1, 2006; 47(9): 1440 - 1446.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y. Nishiyama, Y. Yamamoto, K. Fukunaga, N. Kimura, A. Miki, Y. Sasakawa, H. Wakabayashi, K. Satoh, and M. Ohkawa
Dual-Time-Point 18F-FDG PET for the Evaluation of Gallbladder Carcinoma
J. Nucl. Med., April 1, 2006; 47(4): 633 - 638.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. Kumar, V. A. Loving, A. Chauhan, H. Zhuang, S. Mitchell, and A. Alavi
Potential of Dual-Time-Point Imaging to Improve Breast Cancer Diagnosis with 18F-FDG PET
J. Nucl. Med., November 1, 2005; 46(11): 1819 - 1824.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste
The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
Oncologist, November 1, 2004; 9(6): 633 - 643.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. M. Spence, M. Muzi, D. A. Mankoff, S. F. O'Sullivan, J. M. Link, T. K. Lewellen, B. Lewellen, P. Pham, S. Minoshima, K. Swanson, et al.
18F-FDG PET of Gliomas at Delayed Intervals: Improved Distinction Between Tumor and Normal Gray Matter
J. Nucl. Med., October 1, 2004; 45(10): 1653 - 1659.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.